obesity

Orexigen Scripts Continue Impressive Track
Seeking Alpha
Wed, 01/21/15 - 06:02 pm
Orexigen
obesity
Contrave
5 Obesity Stocks Investors Are Watching
Yahoo/Benzinga
Thu, 01/15/15 - 08:53 am
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
APD334
Vivus
Qsymia
EnteroMedics
devices
Maestro System
Novo Nordisk
Saxenda
FDA clears new obesity device
Seeking Alpha
Wed, 01/14/15 - 10:53 am
obesity
Maestro System
devices
EnteroMedics
FDA
Zafgen's promising obesity drug comes through in another midstage trial
Fierce Biotech
Wed, 01/7/15 - 09:23 am
Zafgen
obesity
beloranib
hypothalamic injury-associated obesity
Novo Nordisk to promote drug to treat obesity in United States
Yahoo/Reuters
Mon, 12/29/14 - 11:13 am
Novo Nordisk
obesity
Saxenda
FDA approves Novo Nordisk's Saxenda, an injectable weight-loss treatment
Yahoo/AP
Wed, 12/24/14 - 08:44 am
Novo Nordisk
FDA
Saxenda
obesity
liraglutide
Orexigen - Contrave Script Numbers Remain Impressive
Seeking Alpha
Mon, 12/22/14 - 04:52 pm
Orexigen
Contrave
obesity
Orexigen diet pill recommended for approval in Europe
Yahoo/Reuters
Fri, 12/19/14 - 09:46 am
Orexigen
obesity
Contrave
Europe
Mysimba
Vivus Tries To Lead Obesity Space With Insurance Coverage
Seeking Alpha
Tue, 12/16/14 - 08:18 am
Vivus
obesity
insurance
Qsymia
Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals
Adam on Biotech Stocks
Fri, 12/12/14 - 12:33 pm
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Belviq
Vivus
Qsymia
Assessing The Beginnings Of The Orexigen Launch Of Contrave
Seeking Alpha
Wed, 12/10/14 - 05:47 pm
Contrave
obesity
Orexigen
drug launches
Takeda
Fonar Is An Unusual And Undervalued Play On The Obesity Epidemic
Seeking Alpha
Mon, 12/8/14 - 11:52 am
FONAR
obesity
devices
MRI
The Odds Of Success For The New Obesity Drugs
CP Wire
Mon, 12/8/14 - 11:45 am
obesity
Belviq
Contrave
Qsymia
Arena Pharmaceuticals
Vivus
Orexigen
Will Diabetes Drugs Enter The Anti-Obesity Space?
Seeking Alpha
Mon, 12/8/14 - 08:30 am
diabetes
obesity
Arena Pharmaceuticals
Novo Nordisk
AstraZeneca
Orexigen
Vivus
Farxiga
Victoza
Invokana
Belviq Sales Remain Flat, Next Week Will Have A Dip
Seeking Alpha
Tue, 12/2/14 - 08:51 am
Belviq
obesity
Arena Pharmaceuticals
Eisai
For This Obesity Drug, Europe Trumps the U.S.
Motley Fool
Tue, 11/18/14 - 10:06 am
Orexigen
Europe
Contrave
obesity
Janssen Is Working Its Way Toward Anti-Obesity
Seeking Alpha
Tue, 11/18/14 - 09:59 am
Janssen
obesity
Invokana
Obesity drug war may be about more than marketing to the overweight
Medical Marketing and Media
Wed, 11/12/14 - 04:52 pm
obesity
Contrave
Orexigen
Eisai
Arena And Vivus Investors Need To Watch Orexigen
Seeking Alpha
Tue, 11/11/14 - 10:38 am
Arena Pharmaceuticals
Orexigen
Vivus
obesity
Novo Nordisk builds blockbuster case with promising PhIII obesity data
Fierce Biotech
Tue, 11/4/14 - 10:39 am
Novo Nordisk
obesity
liraglutide

Pages